Glass is composed of sand, soda ash cullet, and limestone. The composition of these ingredients varies based on the application of the glass. Glass is very versatile and attractive. It can be molded into many shapes, sizes, and colors. Glass is suitable for sterilization and has excellent barrier properties and can be colored to improve light sensitive. Glass packaging preserves the product’s properties such as taste and flavor and protects its contents. Glass is the only material which is widely used as generally recognized as safe (GRAS) by the U.S. Food & Drug Administration.
In the pharmaceutical industry, glass containers for drugs are available in clean flint or amber color. Borosilicate glasses vitals & ampoules are used for sensitive pharmaceuticals such as blood products and parenteral drugs.
Increase in rate of consumption of generic drugs and rise in access to health care are driving the pharmaceutical glass packaging market. However, glass packaging problems, such as breakage, delamination, and particulate contamination, is increasing the competition of plastic. This, in turn, is likely to restrain the market.
Pharmaceutical Glass Packaging Market: Segmentation
Based on product type, the pharmaceutical glass packaging market can be segmented into vials, cartridges & syringes, bottles, and ampoules. The vials segment can be further sub-segmented into small (<30 ml) and large (>30 ml) in terms of volume. Vials are mostly employed for collecting biological samples in the pharmaceutical industry. The vials segment is anticipated to expand at rapid pace during forecast period. The bottles segment can be sub-divided into small (<1000ml) and large (>1000). In terms of revenue, the bottles segment accounted for a major share of the market in 2017. In 2016, Gerresheimer AG introduced Gx RTF vials using its patented Ompi EZ-Fill packaging technology. In terms of drug type, the pharmaceutical glass packaging market can be divided into branded, generic, and biologic.
Pharmaceutical Glass Packaging Market: Region
Based on region, the global pharmaceutical glass packaging market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. In terms of consumption, North America accounted for a major share of the pharmaceutical glass packaging market in 2017. This trend is anticipated to continue during the forecast period. The U.S. is the largest pharmaceutical market in the world. This is anticipated to create lucrative opportunities for companies operating in the pharmaceutical glass packaging market in the country. Europe is estimated to account for large share of the pharmaceutical glass packaging market between 2018 and 2026. In terms of sales, the pharmaceutical glass packaging market in Europe accounted for more than 20% share of the global pharmaceutical market in 2017 which signifies the need for pharmaceutical packaging. Government schemes such as PRIME which supplies Priority Medicine by increasing the support for medicines is expected to be beneficial for the pharmaceutical industry. Asia Pacific is projected to be a promising pharmaceutical glass packaging market during forecast period. Expansion of the medical & pharmaceutical industry in countries such as China, India, Japan, and South Korea due to increasing population and rise in health care infrastructure is projected to boost the pharmaceutical glass packaging market. Surge in disposable income primarily in the middle-class population is resulting in the growth of manufacturing sector thus aiding the pharmaceutical glass packaging market in Asia Pacific during the forecast period. The pharmaceutical glass packaging market in Latin America and Middle East & Africa is likely to expand at a sluggish pace during the forecast period.
Pharmaceutical Glass Packaging Market: Key Players
Large number of companies operate in the global pharmaceutical glass packaging market. Numerous regional and local traders, distributors, and importers supply pharmaceutical glass packaging to end-users. Key players operating in the global pharmaceutical glass packaging market include Corning Inc., SCHOTT AG, GERRESHEIMERE, Stevanato Group S.p.A., West Pharmaceutical Services, Inc., and Stölzle-Oberglas GmbH.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.